Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine ...

Shares of Quest Diagnostics Inc. DGX slid 3.78% to $164.18 Friday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index SPX falling 5.97% to 5,074.08 ...

Redburn Atlantic began coverage on shares of Quest Diagnostics (NYSE:DGX – Free Report) in a report issued on Wednesday morning, MarketBeat reports. The firm issued a buy rating and a $195.00 price ...

In the longer term, DGX stock is up 10.5% on a YTD basis, outpacing SPX’s 2.9% dip. Moreover, shares of Quest Diagnostics have surged 29.3% over the past 52 weeks, compared to the 9.8% return ...

Quest Diagnostics Inc.’s DGX investments in Advanced Diagnostics are paying off, aiming to deliver and scale innovative services that improve patient care and drive growth. The company focuses on ...

Wrapping up Q4 earnings, we look at the numbers and key takeaways for the testing & diagnostics services stocks, including ...

Analysts have set 12-month price targets for Quest Diagnostics, revealing an average target of $179.44, a high estimate of $191.00, and a low estimate of $170.00. This current average has increased by ...

Quest Diagnostics (NYSE:DGX ... Street estimates EPS to be $9.71 per share and revenue to be $10.78B. The stock is down 4% in early trading.

The stock, currently trading near its 52 ... The securities firm's analysis indicates that Quest Diagnostics is expected to continue its positive trajectory, supported by several key factors.

Quest Diagnostics Inc.’s DGX investments in Advanced ... A strong focus on operational excellence is highly encouraging for the stock. Meanwhile, unfavorable solvency and a fierce competitive ...